Perioperative venous thromboembolism in urologic oncology procedures, risk factors, and preventionKukreja, Janet E. BaackCurrent Opinion in Urology: May 2018 - Volume 28 - Issue 3 - p 227–232 doi: 10.1097/MOU.0000000000000491 PERI AND POSTOPERATIVE CARE IN UROLOGIC ONCOLOGY: Edited by Maria J. Ribal and Alon Weizer Buy Abstract Author InformationAuthors Article MetricsMetrics Purpose of review Venous thromboembolism (VTE) is a common complication during the perioperative period for major urologic oncology operations. The present review focuses on the risk factors, the mechanisms of hypercoagulability in this patient population, and the timing and prevention of VTE. Recent findings Although the vast majority of patients undergoing major urologic oncology operations do not develop VTEs, when they do develop they can be fatal. The risk factors for VTEs are important to identify in this patient population. The timing of VTE events are also essential to understanding their prevention. Prevention focused around the perioperative period is the best way to reduce fatal complications secondary to a VTE event. Summary VTEs are common and can potentially be fatal. Prevention in high-risk patients during the most vulnerable perioperative time period should be the focus of clinical efforts to reduce VTE complications and the associated morbidity and mortality. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Correspondence to Janet E. Baack Kukreja, MD, MPH, 1515 Holcombe Blvd. Unit 1373, Houston, TX 77030. Tel: +1 713 792 3250; fax: +1 713 794 4824; e-mail: firstname.lastname@example.org;email@example.com Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.